Concepedia
Statistics
Publications
14
Citations
2.1K
H-Index
Active since
2004
Affiliations
CureVac (Germany)(Current)
University of Tübingen
Technical University of Munich
University Medical Center of the Johannes Gutenberg University Mainz
Johannes Gutenberg University Mainz
Jochen Probst is an author at CureVac (Germany) specializing in immunology, life sciences, and immunotherapy.
Publications per year
2004–2019
Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
Mariola Fotin‐Mleczek, Katharina M. Duchardt, Christina Lorenz et al. · Journal of Immunotherapy · 2010 · 335 citations
Life Sciences, Immunology, Oncology +17
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
Hubert Kübler, Birgit Scheel, Ulrike Gnad-Vogt et al. · Journal for ImmunoTherapy of Cancer · 2015 · 284 citations · Full text
Veterinary Medicine, Immunology, Oncology +17
Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent
Jochen Probst, Benjamin Weide, Birgit Scheel et al. · Gene Therapy · 2007 · 206 citations
Life Sciences, Biochemistry, Molecular Biology +6
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer
Martin Sebastian, Andreas Schröder, Birgit Scheel et al. · Cancer Immunology Immunotherapy · 2019 · 204 citations · Full text
Medicine, Immunology, Oncology +12
Toll‐like receptor‐dependent activation of several human blood cell types by protamine‐condensed mRNA
Birgit Scheel, Regina Teufel, Jochen Probst et al. · European Journal of Immunology · 2005 · 201 citations · Full text
Life Sciences, Immunology, Molecular Biology +14
1–5 of 14